Rchr
J-GLOBAL ID：200901072655230296   Update date: Sep. 08, 2024

Saito Yoshiro

サイトウ ヨシロウ | Saito Yoshiro
Affiliation and department：
National Institute of Health Sciences

About National Institute of Health Sciences


Job title： Deputy Director General
Research field  (2)： Pharmacology ,  Clinical pharmacy
Research keywords  (7)： レギュラトリーサイエンス ,  薬剤疫学 ,  薬物動態学 ,  医薬品安全性学 ,  ゲノム薬理学 ,  Drug-induced adverse effect ,  Pharmacogenomics
Research theme for competitive and other funds  (18)：
  • 2022 - 2025 抗てんかん薬による重症薬疹発症予測のための遺伝子診断薬の開発
  • 2020 - 2023 The elucidation of expression mechanism and biological functions of a novel biomarker for diffuse alveolar damage
  • 2018 - 2022 Research on genomic biomarker exploration on drug-induced liver injury in Japanese, their functional analysis and diagnosis
  • 2015 - 2019 Construction of novel MHC-class II based strategy and evaluation method for drug-induced myopathy.
  • 2014 - 2018 Development of a diagnostic method for severe cutaneous adverse reactions by genom biomarkers and their pathophysiological relevanceic
Show all
Papers (312)：
  • Noriko Sakuma, Mitsuhiro Abe, Daisuke Ishii, Takeshi Kawasaki, Noriaki Arakawa, Shinichiro Matsuyama, Yoshiro Saito, Takuji Suzuki, Koichiro Tatsumi. Serum stratifin measurement is useful for evaluating disease severity and outcomes in patients with acute exacerbation of interstitial lung disease: a retrospective study. BMC pulmonary medicine. 2024. 24. 1. 364-364
  • Tokuyuki Yoshida, Tomoko Hagihara, Yasunori Uchida, Yoshiyuki Horiuchi, Kiyomi Sasaki, Takenori Yamamoto, Takuma Yamashita, Yukihiro Goda, Yoshiro Saito, Takao Yamaguchi, et al. Introduction of sugar-modified nucleotides into CpG-containing antisense oligonucleotides inhibits TLR9 activation. Scientific reports. 2024. 14. 1. 11540-11540
  • Koya Fukunaga, Eri Tsukagoshi, Ryosuke Nakamura, Kayoko Matsunaga, Takeshi Ozeki, Hideaki Watanabe, Akito Hasegawa, Natsumi Hama, Maiko Kurata, Yoshiko Mizukawa, et al. Association of HLA-A∗11:01, HLA-B∗39:01, and HLA-B∗56:03 with salazosulfapyridine-induced cutaneous adverse drug reactions. The Journal of Allergy and Clinical Immunology: In Practice. 2024. 12. 5. 1355-1358
  • Kosuke Saito, Ryoya Goda, Koji Arai, Kota Asahina, Mitsuhiko Kawabata, Hitoshi Uchiyama, Tomohiro Andou, Hisao Shimizu, Kentaro Takahara, Masaaki Kakehi, et al. Interlaboratory evaluation of LC-MS-based biomarker assays. Bioanalysis. 2024. 16. 6. 389-402
  • Shotaro Masuoka, Junko Nishio, Soichi Yamada, Kosuke Saito, Kaichi Kaneko, Makoto Kaburaki, Nahoko Tanaka, Hiroshi Sato, Sei Muraoka, Mai Kawazoe, et al. Relationship Between the Lipidome Profile and Disease Activity in Patients with Rheumatoid Arthritis. Inflammation. 2024
ｍore...
MISC (98)：
ｍore...
Education (4)：
  • - 1989 Kyushu University
  • - 1989 Kyushu University Graduate School, Division of Pharmaceutical Sciences
  • - 1987 Kyushu University School of Pharmaceutical Sciences
  • - 1987 Kyushu University Faculty of Pharmaceutical Science
Professional career (1)：
  • Ph.D. (The University of Tokyo)
Committee career (10)：
  • 2022/10 - 現在 日本免疫毒性学会 理事長
  • 2021/04 - 現在 独)医薬品医療機器総合機構 日本薬局方原案検討委員会, 委員
  • 2019/01 - 現在 厚生労働省 薬事・食品衛生審議会 臨時委員
  • 2015/06 - 現在 日本毒性学会 評議員
  • 2013/09 - 現在 日本免疫毒性学会 理事
Show all
Awards (4)：
  • 2022/11 - 日本薬物動態学会学会賞
  • 2009 - 日本薬物動態学会奨励賞
  • 2008 - 日本免疫毒性学会第15回学術大会奨励賞
  • 2008 - 平成19年度日本薬学会薬学研究ビジョン部会賞
Association Membership(s) (10)：
日本レギュラトリーサイエンス学会 ,  JAPANESE SOCIETY FOR PHARMACOEPIDEMIOLOGY ,  JAPANESE SOCIETY OF PHARMACEUTICAL HEALTH CARE AND SCIENCES ,  THE JAPANESE SOCIETY OF TOXICOLOGY ,  THE JAPANESE SOCIETY OF CLINICAL PHARMACOLOGY AND THERAPEUTICS ,  日本薬物動態学会 ,  日本薬学会 ,  日本免疫毒性学会 ,  Society for toxicology ,  International Society for the study of Xenobiotics
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM